Concussions happen more often than you think. They can happen anywhere, and they don’t just happen during sports. Most concussions occur when people slip and fall during the activities of everyday life.
Even so, it can be difficult to tell the difference between a bump on the head and a concussion, or mild traumatic brain injury (TBI). Some of the current methods for evaluating a concussion can lead to more questions than answers.
Fortunately, there are lab-based concussion tests that can help bring some clarity to the process.
Abbott’s concussion blood tests – on its Alinity i and i-STAT Alinity instruments – measure two biomarkers that are released into the bloodstream when the brain is injured*. They can help doctors better evaluate someone that may have suffered a concussion and help to rule out the need for a head CT scan when there is an absence of these biomarkers in someone’s blood.
The Alinity i TBI test received U.S. Food and Drug Administration clearance in March. It is the first commercially available core laboratory traumatic brain injury blood test, which could become widely available in hospital emergency rooms across the United States. The test complements Abbott's i-STAT TBI Plasma test, the first rapid, blood test for concussion on a portable instrument, which the FDA also cleared. The first hospital to adopt one of Abbott’s concussion blood tests in its ERs was Tampa General Hospital in Florida.
Share